Beyond testosterone, ashwagandha influences stress and arousal pathways that affect desire. This article reviews the libido evidence in men and women.
Ashwagandha Libido is one of the most searched topics in the adaptogen space, yet the clinical evidence behind it is narrower than marketing suggests. For adults navigating stress-related declines in sexual desire, understanding what the research actually supports — and where it falls silent — matters more than any supplement label claim. This article examines the evidence for ashwagandha's effects on libido in both men and women, with no inflated promises.
What the Research Actually Shows
The direct link between ashwagandha and libido has not been studied in large, well-controlled trials. None of the major randomized controlled trials (RCTs) on this herb used sexual desire as a primary endpoint. Instead, the connection is inferred through related outcomes: stress reduction, cortisol modulation, and in men, testosterone support. These pathways are biologically plausible, but the leap from "reduces anxiety" to "improves libido" requires careful qualification.
Chandrasekhar et al. (2012) conducted a prospective, randomized double-blind, placebo-controlled study of a high-concentration full-spectrum ashwagandha root extract in adults with chronic stress. The 64 participants who received 300 mg twice daily for 60 days showed significant reductions in serum cortisol and perceived stress scores compared to placebo. Cortisol and sexual desire are inversely related in both sexes; chronically elevated cortisol suppresses gonadotropin-releasing hormone (GnRH) pulsatility, which dampens downstream sex hormone production. This study did not measure libido directly, but it established a mechanistic bridge worth noting.
Langade et al. (2019) tested ashwagandha root extract in patients with insomnia and anxiety, using 300 mg twice daily for 10 weeks. Sleep quality improved significantly in the treatment group. Poor sleep is one of the most underappreciated libido suppressors; sleep restriction lowers testosterone in men and disrupts estrogen cycling in women. Again, no sexual function outcomes were collected, but the sleep-stress-libido axis is well-documented in endocrinology.
Wankhede et al. (2015) studied ashwagandha in healthy men undergoing resistance training, using 300 mg of root extract twice daily for 8 weeks. The treatment group showed greater increases in muscle strength and testosterone compared to placebo. Total testosterone rose approximately 15% from baseline. This is the closest any included study comes to a libido-relevant hormonal outcome in men, though sexual desire was not assessed.
Choudhary et al. (2017) examined memory and cognitive function in healthy adults using 300 mg twice daily for 8 weeks. While the focus was on executive function and reaction time, the researchers noted improvements in perceived stress. Pratte et al. (2014) conducted a systematic review of human trial results for ashwagandha in anxiety, concluding that the herb shows promise but that existing trials are limited by small sample sizes, short durations, and methodological variability. This caveat applies equally to any libido-related claims.
How It Might Work: The Mechanism
Ashwagandha's primary bioactive constituents are withanolides, steroidal lactones that interact with the hypothalamic-pituitary-adrenal (HPA) axis and, indirectly, the hypothalamic-pituitary-gonadal (HPG) axis. The mechanism is not aphrodisiac in the classical sense; it does not directly stimulate genital blood flow or spinal sexual reflexes. Instead, it operates upstream.
Cortisol Modulation
Withanolides appear to reduce cortisol secretion by modulating the HPA axis response to perceived stress. Lower cortisol reduces negative feedback on GnRH neurons in the hypothalamus. In men, this permits greater pulsatile luteinizing hormone (LH) release, which drives testicular testosterone synthesis. In women, lower cortisol can restore cyclic GnRH pulsatility, supporting estrogen and progesterone rhythms that underpin sexual desire in the follicular and ovulatory phases. This is not a direct hormonal boost; it is a restoration of normal regulatory tone.
GABA-Mimetic and Anti-Anxiety Effects
Ashwagandha has GABA receptor-modulating properties, which may reduce performance anxiety and psychological barriers to sexual desire. The Pratte et al. (2014) review highlighted consistent anxiolytic effects across multiple human trials. For individuals whose low libido is entangled with stress, rumination, or anticipatory anxiety, this mechanism is clinically relevant even if it does not address physiological desire directly.
Testosterone and Nitric Oxide in Men
Wankhede et al. (2015) demonstrated a testosterone increase in exercising men, likely mediated by reduced cortisol-mediated suppression of Leydig cell function and possibly by direct withanolide effects on steroidogenesis enzymes. Testosterone supports libido, erectile function, and sexual motivation. However, the magnitude of change in this study was modest, and baseline testosterone levels were within normal range. Men with clinically low testosterone were not studied.
What About Women?
No included study examined ashwagandha's effects on female sex hormones or sexual desire. The mechanistic rationale for women rests on cortisol reduction, sleep improvement, and HPA axis restoration — all of which can indirectly support desire in women with stress-related hypoarousal. But this is theoretical. Human data is limited.
Study Characteristics at a Glance
| Study | Population | Dose & Duration | Primary Outcome | Libido-Relevant Finding |
|---|---|---|---|---|
| Chandrasekhar et al. (2012) | Adults with chronic stress (n=64) | 300 mg BID, 60 days | Cortisol, perceived stress | Significant cortisol reduction; libido not measured |
| Langade et al. (2019) | Patients with insomnia/anxiety (n=60) | 300 mg BID, 10 weeks | Sleep quality, anxiety scores | Improved sleep; libido not measured |
| Wankhede et al. (2015) | Healthy men, resistance training (n=57) | 300 mg BID, 8 weeks | Muscle strength, testosterone | ~15% testosterone increase; libido not measured |
| Choudhary et al. (2017) | Healthy adults (n=50) | 300 mg BID, 8 weeks | Memory, cognitive function | Stress reduction noted; libido not measured |
| Pratte et al. (2014) | Systematic review of anxiety trials | Varied | Anxiety outcomes | Promise noted; small sample sizes, limited libido data |
What the Evidence Does Not Show
It is important to be precise about the gaps. No included study used a validated sexual function questionnaire such as the Female Sexual Function Index (FSFI) or the International Index of Erectile Function (IIEF). No study examined ashwagandha in postmenopausal women, in men with diagnosed hypogonadism, or in couples with relationship-related desire discordance. The evidence does not support ashwagandha as a treatment for clinical sexual dysfunction or as a standalone substitute for hormone therapy, psychotherapy, or relationship counseling.
Marketing that frames ashwagandha as a "natural libido booster" overreaches. The herb may restore desire that was suppressed by stress, poor sleep, or suboptimal testosterone — but it is not a stimulant in the way that, for example, phosphodiesterase inhibitors are for erectile function. Expectations should be calibrated accordingly.
Who Benefits Most
The evidence profile suggests ashwagandha is most likely to support libido in specific, identifiable populations:
Men with stress-related testosterone suppression. Wankhede et al. (2015) showed testosterone gains in healthy, stressed men undergoing training. Men with high cortisol and borderline-low testosterone may see the most hormonal benefit. For a deeper look at testosterone-specific evidence, see our article on Ashwagandha & Testosterone.
Women with HPA axis dysregulation. Women experiencing low desire in the context of chronic stress, poor sleep, or burnout may benefit indirectly from cortisol reduction and sleep restoration. However, this is based on mechanism and sleep data, not direct female sexual function trials. Women interested in broader hormonal support may find our guide on Ashwagandha for Women useful.
Individuals with anxiety-related sexual avoidance. The anxiolytic effects documented by Chandrasekhar et al. (2012) and Pratte et al. (2014) suggest ashwagandha may help those whose libido is constrained by anticipatory anxiety, performance pressure, or generalized worry. This is a psychological mechanism, not a hormonal one.
Couples planning conception. While libido itself was not studied, the testosterone and stress effects may support sexual frequency in couples trying to conceive. Our review of Ashwagandha & Fertility covers the reproductive evidence in more detail.
Form, Dose, and Quality Considerations
The included studies used root extracts standardized to withanolide content, typically at 300 mg twice daily. This is the most evidence-backed dosing framework currently available. Full-spectrum extracts retain the natural ratio of withanolides and other root constituents, which may offer synergistic effects beyond isolated compounds.
KSM-66 is a specific full-spectrum root extract used in several clinical trials, including some of the studies above. It is prepared using a milk-pretraction process that preserves the raw root's bioactive profile. For readers considering a standardized option, Bio:sudo KSM-66 Reishi Restore combines this extract with Reishi mushroom for additional adaptogenic support. The inclusion of Reishi does not directly affect libido evidence but may appeal to those seeking broader stress resilience.
Timing matters. Morning and evening dosing splits the cortisol-modulating effect across the circadian cycle. Taking ashwagandha with food improves tolerability and may enhance lipophilic constituent absorption.
Practical Takeaways
- Evidence is indirect. No included study measured libido directly. The connection is inferred through stress, sleep, and testosterone pathways.
- Dose consistently. The studied dose is 300 mg of standardized root extract twice daily. Benefits, where they occur, typically emerge after 4–8 weeks.
- Men have more hormonal data. Wankhede et al. (2015) showed testosterone increases in exercising men. Women have no direct sexual function trials in the included literature.
- Stress reduction is the strongest link. Chandrasekhar et al. (2012) and Langade et al. (2019) both support cortisol and sleep improvement, which are upstream of healthy sexual desire.
- Do not use as a substitute for clinical care. Persistent low libido, erectile dysfunction, or sexual pain warrant evaluation by a qualified clinician. Ashwagandha is a supportive adjunct, not a treatment.
- Choose standardized extracts. Look for root extracts with disclosed withanolide content. Bio:sudo KSM-66 Reishi Restore is one option that uses a clinically studied extraction method.
Bottom Line
Ashwagandha may support libido in both sexes, but the evidence is indirect and incomplete. The strongest case exists for men with stress-related testosterone suppression and for anyone whose low desire is tied to chronic stress, poor sleep, or anxiety. For women, the mechanism is plausible but human data is limited. It is a reasonable adjunct for stress-related sexual health concerns, not a standalone solution for clinical dysfunction.
References
- Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine. 2012;34(3):255–262. [Source]
- Langade D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
- Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." Journal of the International Society of Sports Nutrition. 2015;12:43. [Source]
- Choudhary D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in improving memory and cognitive functions." Journal of Dietary Supplements. 2017;14(6):599–612. [Source]
- Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." Journal of Alternative and Complementary Medicine. 2014;20(12):901–908. [Source]
Try This Protocol
KSM-66® ashwagandha 600 mg · clinically studied extract · COA available
Shop Now →